Return of individual research results from genomic research: A systematic review of stakeholder perspectives

Despite the plethora of empirical studies conducted to date, debate continues about whether and to what extent results should be returned to participants of genomic research. We aimed to systematically review the empirical literature exploring stakeholders’ perspectives on return of individual resea...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Danya F. Vears, Joel T. Minion, Stephanie J. Roberts, James Cummings, Mavis Machirori, Mwenza Blell, Isabelle Budin-Ljøsne, Lorraine Cowley, Stephanie O. M. Dyke, Clara Gaff, Robert Green, Alison Hall, Amber L. Johns, Bartha M. Knoppers, Stephanie Mulrine, Christine Patch, Eva Winkler, Madeleine J. Murtagh
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/08013997ec0e494496b417420b999001
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:08013997ec0e494496b417420b999001
record_format dspace
spelling oai:doaj.org-article:08013997ec0e494496b417420b9990012021-11-18T06:22:37ZReturn of individual research results from genomic research: A systematic review of stakeholder perspectives1932-6203https://doaj.org/article/08013997ec0e494496b417420b9990012021-01-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8575249/?tool=EBIhttps://doaj.org/toc/1932-6203Despite the plethora of empirical studies conducted to date, debate continues about whether and to what extent results should be returned to participants of genomic research. We aimed to systematically review the empirical literature exploring stakeholders’ perspectives on return of individual research results (IRR) from genomic research. We examined preferences for receiving or willingness to return IRR, and experiences with either receiving or returning them. The systematic searches were conducted across five major databases in August 2018 and repeated in April 2020, and included studies reporting findings from primary research regardless of method (quantitative, qualitative, mixed). Articles that related to the clinical setting were excluded. Our search identified 221 articles that met our search criteria. This included 118 quantitative, 69 qualitative and 34 mixed methods studies. These articles included a total number of 118,874 stakeholders with research participants (85,270/72%) and members of the general public (40,967/35%) being the largest groups represented. The articles spanned at least 22 different countries with most (144/65%) being from the USA. Most (76%) discussed clinical research projects, rather than biobanks. More than half (58%) gauged views that were hypothetical. We found overwhelming evidence of high interest in return of IRR from potential and actual genomic research participants. There is also a general willingness to provide such results by researchers and health professionals, although they tend to adopt a more cautious stance. While all results are desired to some degree, those that have the potential to change clinical management are generally prioritized by all stakeholders. Professional stakeholders appear more willing to return results that are reliable and clinically relevant than those that are less reliable and lack clinical relevance. The lack of evidence for significant enduring psychological harm and the clear benefits to some research participants suggest that researchers should be returning actionable IRRs to participants.Danya F. VearsJoel T. MinionStephanie J. RobertsJames CummingsMavis MachiroriMwenza BlellIsabelle Budin-LjøsneLorraine CowleyStephanie O. M. DykeClara GaffRobert GreenAlison HallAmber L. JohnsBartha M. KnoppersStephanie MulrineChristine PatchEva WinklerMadeleine J. MurtaghPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 16, Iss 11 (2021)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Danya F. Vears
Joel T. Minion
Stephanie J. Roberts
James Cummings
Mavis Machirori
Mwenza Blell
Isabelle Budin-Ljøsne
Lorraine Cowley
Stephanie O. M. Dyke
Clara Gaff
Robert Green
Alison Hall
Amber L. Johns
Bartha M. Knoppers
Stephanie Mulrine
Christine Patch
Eva Winkler
Madeleine J. Murtagh
Return of individual research results from genomic research: A systematic review of stakeholder perspectives
description Despite the plethora of empirical studies conducted to date, debate continues about whether and to what extent results should be returned to participants of genomic research. We aimed to systematically review the empirical literature exploring stakeholders’ perspectives on return of individual research results (IRR) from genomic research. We examined preferences for receiving or willingness to return IRR, and experiences with either receiving or returning them. The systematic searches were conducted across five major databases in August 2018 and repeated in April 2020, and included studies reporting findings from primary research regardless of method (quantitative, qualitative, mixed). Articles that related to the clinical setting were excluded. Our search identified 221 articles that met our search criteria. This included 118 quantitative, 69 qualitative and 34 mixed methods studies. These articles included a total number of 118,874 stakeholders with research participants (85,270/72%) and members of the general public (40,967/35%) being the largest groups represented. The articles spanned at least 22 different countries with most (144/65%) being from the USA. Most (76%) discussed clinical research projects, rather than biobanks. More than half (58%) gauged views that were hypothetical. We found overwhelming evidence of high interest in return of IRR from potential and actual genomic research participants. There is also a general willingness to provide such results by researchers and health professionals, although they tend to adopt a more cautious stance. While all results are desired to some degree, those that have the potential to change clinical management are generally prioritized by all stakeholders. Professional stakeholders appear more willing to return results that are reliable and clinically relevant than those that are less reliable and lack clinical relevance. The lack of evidence for significant enduring psychological harm and the clear benefits to some research participants suggest that researchers should be returning actionable IRRs to participants.
format article
author Danya F. Vears
Joel T. Minion
Stephanie J. Roberts
James Cummings
Mavis Machirori
Mwenza Blell
Isabelle Budin-Ljøsne
Lorraine Cowley
Stephanie O. M. Dyke
Clara Gaff
Robert Green
Alison Hall
Amber L. Johns
Bartha M. Knoppers
Stephanie Mulrine
Christine Patch
Eva Winkler
Madeleine J. Murtagh
author_facet Danya F. Vears
Joel T. Minion
Stephanie J. Roberts
James Cummings
Mavis Machirori
Mwenza Blell
Isabelle Budin-Ljøsne
Lorraine Cowley
Stephanie O. M. Dyke
Clara Gaff
Robert Green
Alison Hall
Amber L. Johns
Bartha M. Knoppers
Stephanie Mulrine
Christine Patch
Eva Winkler
Madeleine J. Murtagh
author_sort Danya F. Vears
title Return of individual research results from genomic research: A systematic review of stakeholder perspectives
title_short Return of individual research results from genomic research: A systematic review of stakeholder perspectives
title_full Return of individual research results from genomic research: A systematic review of stakeholder perspectives
title_fullStr Return of individual research results from genomic research: A systematic review of stakeholder perspectives
title_full_unstemmed Return of individual research results from genomic research: A systematic review of stakeholder perspectives
title_sort return of individual research results from genomic research: a systematic review of stakeholder perspectives
publisher Public Library of Science (PLoS)
publishDate 2021
url https://doaj.org/article/08013997ec0e494496b417420b999001
work_keys_str_mv AT danyafvears returnofindividualresearchresultsfromgenomicresearchasystematicreviewofstakeholderperspectives
AT joeltminion returnofindividualresearchresultsfromgenomicresearchasystematicreviewofstakeholderperspectives
AT stephaniejroberts returnofindividualresearchresultsfromgenomicresearchasystematicreviewofstakeholderperspectives
AT jamescummings returnofindividualresearchresultsfromgenomicresearchasystematicreviewofstakeholderperspectives
AT mavismachirori returnofindividualresearchresultsfromgenomicresearchasystematicreviewofstakeholderperspectives
AT mwenzablell returnofindividualresearchresultsfromgenomicresearchasystematicreviewofstakeholderperspectives
AT isabellebudinljøsne returnofindividualresearchresultsfromgenomicresearchasystematicreviewofstakeholderperspectives
AT lorrainecowley returnofindividualresearchresultsfromgenomicresearchasystematicreviewofstakeholderperspectives
AT stephanieomdyke returnofindividualresearchresultsfromgenomicresearchasystematicreviewofstakeholderperspectives
AT claragaff returnofindividualresearchresultsfromgenomicresearchasystematicreviewofstakeholderperspectives
AT robertgreen returnofindividualresearchresultsfromgenomicresearchasystematicreviewofstakeholderperspectives
AT alisonhall returnofindividualresearchresultsfromgenomicresearchasystematicreviewofstakeholderperspectives
AT amberljohns returnofindividualresearchresultsfromgenomicresearchasystematicreviewofstakeholderperspectives
AT barthamknoppers returnofindividualresearchresultsfromgenomicresearchasystematicreviewofstakeholderperspectives
AT stephaniemulrine returnofindividualresearchresultsfromgenomicresearchasystematicreviewofstakeholderperspectives
AT christinepatch returnofindividualresearchresultsfromgenomicresearchasystematicreviewofstakeholderperspectives
AT evawinkler returnofindividualresearchresultsfromgenomicresearchasystematicreviewofstakeholderperspectives
AT madeleinejmurtagh returnofindividualresearchresultsfromgenomicresearchasystematicreviewofstakeholderperspectives
_version_ 1718424457803988992